Your browser doesn't support javascript.
loading
Safety and effectiveness of istradefylline as add-on therapy to levodopa in patients with Parkinson's disease: Final report of a post-marketing surveillance study in Japan.
Takahashi, Makio; Ito, Satoru; Tsuji, Yukie; Horiguchi, Shuji.
Affiliation
  • Takahashi M; Department of Neurology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka, Japan. Electronic address: ta@kuhp.kyoto-u.ac.jp.
  • Ito S; Pharmacovigilance Division, Kyowa Kirin Co., Ltd., Tokyo, Japan. Electronic address: satoru.itou.fh@kyowakirin.com.
  • Tsuji Y; Pharmacovigilance Division, Kyowa Kirin Co., Ltd., Tokyo, Japan. Electronic address: yukie.tsuji.dq@kyowakirin.com.
  • Horiguchi S; Pharmacovigilance Division, Kyowa Kirin Co., Ltd., Tokyo, Japan. Electronic address: shuji.horiguchi.dh@kyowakirin.com.
J Neurol Sci ; 443: 120479, 2022 12 15.
Article in En | MEDLINE | ID: mdl-36395674
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Drug-Related Side Effects and Adverse Reactions Type of study: Observational_studies / Screening_studies Limits: Adult / Aged / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: J Neurol Sci Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Drug-Related Side Effects and Adverse Reactions Type of study: Observational_studies / Screening_studies Limits: Adult / Aged / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: J Neurol Sci Year: 2022 Document type: Article Country of publication: